ProKidney Corp. Profile Avatar - Palmy Investing

ProKidney Corp.

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II cl…

Biotechnology
US, Winston-Salem [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

Searching for a Dividend Aristocrat? Sign Up to view the entire dividend history of ProKidney Corp.

Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of PROK's Analysis
CIK: 1850270 CUSIP: - ISIN: KYG7S53R1049 LEI: - UEI: -
Secondary Listings
PROK has no secondary listings inside our databases.